Background and Aims Interleukin‐22 has beneficial effects on inflammation and impaired
hepatic regeneration that characterize alcohol‐associated hepatitis (AH). F‐652 is a …

Abstract Interleukin‐22 (IL‐22) plays a key role in promoting antimicrobial immunity and
tissue repair at barrier surfaces by binding to the receptors IL‐22 R 1, which is generally …

Abstract Interleukin‐22 (IL‐22), a recently identified member of the IL‐10 family of cytokines
that is produced by Th17 and natural killer cells, plays an important role in controlling …

The activation of innate immunity by various factors (eg lipopolysaccharide and
complements) plays an important role in initiating and promoting alcoholic liver injury via the …

Immune dysregulations in alcoholic liver diseases are still unclear, especially regarding
alcoholic hepatitis inflammatory burst. Interleukin‐17 (IL‐17) is known to enhance neutrophil …

Background/Aims: The aim of this study is to evaluate the tolerance and effects of infliximab
combined with steroids in severe alcoholic hepatitis (AH). Methods: Twenty patients with …

BACKGROUND Alcoholic hepatitis is a cause of major morbidity and mortality, and effective
therapeutic regimens to treat this condition are lacking. Both experimental and clinical …

It is well established that interleukin (IL)‐22 has hepatoprotective and antifibrotic functions in
acute liver injury models; however, its function in patients with liver fibrosis and liver cirrhosis …

Background & Aims Chronic alcohol consumption is a leading risk factor for the
development of hepatocellular carcinoma (HCC), which is associated with a marked …

Nonalcoholic fatty liver disease (NAFLD) is a metabolic disorder due to increased
accumulation of fat in the liver and in many cases to enhanced inflammation. Although the …